| Autor: |
Essiaw LA; Department of Biochemistry, Cell & Molecular Biology, West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana., Bolarinwa A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Tang H; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Kudowor G; Department of Biochemistry, Cell & Molecular Biology, West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana., Shivaram S; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Sharma N; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Linden MA; Division of Hematopathology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Buadi FK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Kumar S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Dei-Adomakoh Y; Department of Haematology, University of Ghana Medical School/Korle Bu Teaching Hospital, Accra, Ghana., Cook JM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Baughn LB; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. Electronic address: baughn.linda@mayo.edu., Paemka L; Department of Biochemistry, Cell & Molecular Biology, West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana. Electronic address: lpaemka@ug.edu.gh. |
| Abstrakt: |
Competing Interests: Disclosure S.K.K. served as a consultant for Celgene, Takeda, Amgen, Janssen, and Bristol-Myers Squibb and received research funding from Celgene, Takeda, Novartis, Amgen, AbbVie, Janssen, and Bristol-Myers Squibb. L.B.B. served as a consultant for Genentech. |
Full Text from ScienceDirect